DMAA · CIK 0002028614
DRUGS MADE IN AMERICA ACQUISITION CORP.
Annual figures as reported, FY2024–FY2025. Ratios and growth rates derived on-page.
Blank Checks
Company profile
Net income
$5.9M
Operating cash flow
−$539K
Total assets
$239.9M
▲ +43456.4% vs FY2024
Recent quarters
momentum · last 12 quartersNet income — Mar ’26 quarter
$2.0M
▲ +57.1% vs Mar ’25
Quarterly net income
Losses shown in terracotta
| Quarter | Revenue | Rev. YoY | Gross margin | Net income | Net margin | Diluted EPS |
|---|---|---|---|---|---|---|
| Mar ’26 | — | — | — | $2.0M | — | — |
| Dec ’25 | — | — | — | $213K | — | — |
| Sep ’25 | — | — | — | $2.2M | — | — |
| Jun ’25 | — | — | — | $2.3M | — | — |
| Mar ’25 | — | — | — | $1.3M | — | — |
| Sep ’24 | — | — | — | −$145K | — | — |
Balance sheet
financial positionStockholders’ equity
At fiscal year end
Key ratios
derived per fiscal year| Fiscal year | ROA | Current ratio |
|---|---|---|
| FY2025 | 2.5% | 0.03× |
| FY2024 | — | 0.01× |
Annual figures
as reported| Fiscal year | Revenue | Gross profit | Op. income | Net income | Diluted EPS | Op. cash flow | Capex | Total assets | Liabilities | Equity | Cash | LT debt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 | — | — | −$2.8M | $5.9M | — | −$539K | — | $239.9M | $7.3M | −$7.3M | $6K | — |
| FY2024 | — | — | — | — | — | — | — | $551K | $796K | −$245K | $1K | — |
Latest filings
the most recent regulatory filingsSCHEDULE 13GSEC filing2026-06-26 ↗10-QQUARTERLY REPORT2026-05-14 ↗SCHEDULE 13GSEC filing2026-05-14 ↗425CURRENT REPORT2026-05-05 ↗8-KCURRENT REPORT2026-05-05 ↗8-KCURRENT REPORT2026-05-01 ↗8-KCURRENT REPORT2026-04-28 ↗DEFR14AREVISED DEFINITIVE PROXY STATEMENT2026-04-16 ↗10-KANNUAL REPORT2026-04-15 ↗DEF 14APROXY STATEMENT2026-04-14 ↗
Company logos by Elbstream and unavatar.
All third-party trademarks, service marks, logos, and brand names used on this site are the property of their respective owners. The use of these logos is for identification and illustrative purposes only and does not imply any affiliation, sponsorship, or endorsement by the respective owners.